Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4279-4288

  Vonlanthen, Silvia ^a   Kawecki, Tadeusz J ^a   Betticher, Daniel C ^b   Pfefferli, Martine ^a   Schwaller, Beat ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

Calcium binding protein; Calretinin; Colon cancer; EF hand; Tumor marker

Indexed keywords

CALRETININ;

AGED; ARTICLE; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTRON; LUNG TUMOR; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BASE SEQUENCE; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; COLONIC NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTRONS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 37549025336     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Skibber JM, Minsky BD and Hoff PM: In: Cancer: Principles and Practice of Oncology. de Vita V, Hellman S and Rosenberg SA (eds.). Lippincott Williams, Philadelphia, pp. 1216-1271, 2001.
2. Smith RA, Mettlin CJ, Davis KJ and Eyre H: American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 50: 34-49, 2000.
3. Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo AM, Monti F, Saragoni L and Amadori D: Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. J Cell Physiol 204: 484-488, 2005.
4. Boccia S, La Torre G, Gianfagna F, Mannocci A and Ricciardi G: Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis, pp. 115-123, 2006.
5. Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S and Harris CC: Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer 118: 1790-1797, 2006.
6. Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C and Johnston PG: Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res 66: 2765-2777, 2006.
7. 2+-binding properties of human recombinant calretinin-22k and calretinin. J Biol Chem 272: 29663-29671, 1997.
8. Kawasaki H and Kretsinger RH: Calcium-binding proteins 1: EF-hands. Protein Profile 1: 343-517, 1994.
9. Baimbridge KG, Celio MR and Rogers JH: Calcium-binding proteins in the nervous system. Trends Neurosci 15: 303-308, 1992.
10. Gall D, Roussel C, Susa I, D'Angelo E, Rossi P, Bearzatto B, Galas MC, Blum D, Schurmans S and Schiffmann SN: Altered neuronal excitability in cerebellar granule cells of mice lacking calretinin. J Neurosci 23: 9320-9327, 2003.
11. Andressen C, Blümcke I and Celio MR: Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271: 181-208, 1993.
12. Schwaller B, Meyer M and Schiffmann S: 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1: 241-258, 2002.
13. Gotzos V, Schwaller B, Gander JC, Bustos-Castillo M and Celio MR: Heterogeneity of expression of the calcium-binding protein calretinin in human colonic cancer cell lines. Anticancer Res 16: 3491-3498, 1996.
14. Gotzos V, Wintergerst ES, Musy JP, Spichtin HP and Genton CY: Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol 23: 701-711, 1999.
15. Doglioni C, Tos APD, Laurino L, Iuzzolino P, Chiarelli C, Celio MR and Viale G: Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surgical Pathol 20: 1037-1046, 1996.
16. Gotzos V, Vogt P and Celio MR: The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 192: 137-147, 1996.
17. Gander J-C, Bustos-Castillo M, Stüber D, Hunziker W, Celio MR and Schwaller B: The calcium-binding protein calretinin-22k, an alternative splicing product of the calretinin gene is expressed in several colon adenocarcinoma cell lines. Cell Calcium 20: 63-72, 1996.
18. Schwaller B, Celio MR and Doglioni C: Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases. Anticancer Res 24: 4003-4009, 2004.
19. Marilley D, Vonlanthen S, Gloria A and Schwaller B: Calretinin and calretinin-22k increase resistance towards sodium butyrate-induced differentiation in CaCo-2 colon adenocarcinoma cells. Exp Cell Res 268: 93-103, 2001.
20. Marilley D and Schwaller B: Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr. Exp Cell Res 259: 12-22, 2000.
21. Malkinson AM and You M: The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog 10: 61-65, 1994.
22. Peller S, Kopilova Y, Slutzki S, Halevy A, Kvitko K and Rotter V: A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol 14: 983-990, 1995.
23. Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Fogel M, Cohen IJ, Stark B, Goshen Y, Stein J and Zaizov R: A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene 14: 1541-1545, 1997.
24. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R and Turner BC: Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60: 1062-1069, 2000.
25. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL and Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175, 2000.
26. Saydan N, Salicio V, Cappelli-Gotzos B and Gotzos V: Expression of calretinin in human mesothelioma cell lines and cell cycle analysis by flow cytometry. Anticancer Res 21: 181-188, 2001.
27. Gotzos V, Schwaller B, Hetzel N, Bustos-Castillo M and Celio MR: Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle. Exp Cell Res 202: 292-302, 1992.
28. Schwaller B, Buchwald P, Blumcke I, Celio MR and Hunziker W: Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 14: 639-648, 1993.
29. Sokal RR and Rohlf FJ: Biometry: the principles and practice of statistics in biological research. Third edition. W.H. Freeman and Co, New York, 1995.
30. Schwaller B, Meyer-Monard S, Gander J-C, Pugin P, Celio MR and Ludwig C: The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patients. Anticancer Res 18: 3361-3367, 1998.
31. Cho KR and Vogelstein B: Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem Suppl 16G: 137-141, 1992.
32. Wiethege T, Krismann M and Müller K-M: Value of different antibodies to calretinin as a marker for mesotheliomas. Path Res Pract 195: 298 (Abstract), 1999.
33. Schwaller B, Celio MR and Hunziker W: Alternative splicing of calretinin mRNA leads to different forms of calretinin. Eur J Biochem 230: 424-430, 1995.
34. Braungart E, Schumacher C, Hartmann E, Nekarda H, Becker KF, Hofler H and Atkinson MJ: Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer. J Pathol 187: 530-534, 1999.
35. Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V and Ingvarsson S: Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 1: 16, 2001.
36. Barshishat M, Polak-Charcon S and Schwartz B: Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br J Cancer 82: 195-203, 2000.
37. Schwaller B and Herrmann B: Regulated redistribution of calretinins in WiDr cells. Cell Death Differ 4: 325-333, 1997.
38. Cargnello R, Celio MR, Schwaller B and Gotzos V: Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation. Biochim Biophys Acta 1313: 201-208, 1996.
39. Rolley N, Butcher S and Milner J: Specific DNA binding by different classes of human p53 mutants. Oncogene 11: 763-770, 1995.
40. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA and Hemminki K: A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 95: 388-393, 2001.
41. Angeloni D, Duh FM, Wei MF, Johnson BE and Lerman MI: A G-to-A single nucleotide polymorphism in intron 2 of the human CACNA2D2 gene that maps at 3p21.3. Mol Cell Probes 15: 125-127, 2001.
42. Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM and Iacopetta B: Associations between common polymorphisms in TP53 and p21/WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis 23: 311-315, 2002.
43. Leone PE, Mendiola M, Alonso J, Paz-y-Mino C and Pestana A: Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker. BMC Cancer 3: 6, 2003.